Autolus Therapeutics plc American Depositary Share (AUTL) is a publicly traded Healthcare sector company. As of September 4, 2026, AUTL trades at $2.29 with a market cap of $596.20M and a P/E ratio of -2.11. AUTL moved +2.23% today. Year to date, AUTL is +22.46%; over the trailing twelve months it is +57.93%. Its 52-week range spans $1.11 to $2.70. Analyst consensus is strong buy with an average price target of $8.16. Rallies surfaces AUTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks AUTL insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.29 |
| Market Cap | $596.20M |
| P/E Ratio | -2.11 |
| EPS | $-1.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.70 |
| 52-Week Low | $1.11 |
| Volume | 1.69M |
| Avg Volume | 0 |
| Revenue (TTM) | $75.39M |
| Net Income | $-287.53M |
| Gross Margin | -27.83% |
6 analysts cover AUTL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.16.